5 h. ago Indian pharma giant Cipla inks deal to sell Eli Lilly’s weight

Indian pharma giant Cipla inks deal to sell Eli Lilly’s weight-loss drug under a different brand name: Why is this significant?  The Indian Express

Politics

16 h. ago Eli Lilly allows Cipla to sell weight loss drug under new brand in India

Eli Lilly allows Cipla to sell weight loss drug under new brand in India  Reuters

Economics

2 w. ago UK and India Ink $468 Million Missile Deal, Signalling Deepening Defence Partnership

UK and India Ink $468 Million Missile Deal, Signalling Deepening Defence Partnership  Modern Diplomacy

Economics

2 w. ago Trump & Co said to have shelved generic drug tariffs, Indian pharma stocks get booster dose

Trump & Co said to have shelved generic drug tariffs, Indian pharma stocks get booster dose  The Economic Times

Politics

2 w. ago White House shelves tariffs on generic drugs, sparing bitter pill for American patients and Indian pharma

White House shelves tariffs on generic drugs, sparing bitter pill for American patients and Indian pharma  Times of India

Events

3 w. ago Additional 5–8% Tariffs If No Deal Inked: Trump Warns Pharma Companies

Donald Trump's warning to drugmakers came shortly after Pfizer entered into a pact that offers it three-year reprieve from tariffs.

Events

3 w. ago Trump’s tariffs on pharma sharpen challenge for India’s policymakers

Trump’s tariffs on pharma sharpen challenge for India’s policymakers  The Indian Express

Politics

3 w. ago SCTE Inks Deal to Establish First International Licensee In India

SCTE Inks Deal to Establish First International Licensee In India  TVTechnology

Politics

3 w. ago Bharat Electronics Bags Additional Defence Orders Worth Rs 1,092 Crore

The most recent notable order won by the firm was the Rs 30,000 crore missile deal that the firm inked with the Indian Army for the sale of missile systems.

Politics

3 w. ago Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure

Goldman Sachs has said the move won't have too much of an impact on Indian pharma companies, as a majority of them rely on generics as the main revenue stream.

Events

3 w. ago US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact

Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US, about 17% of 2024-25 revenue.

Events

3 w. ago Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market

Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market  FinancialContent

Politics

3 w. ago Trump's 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explain

Trump's 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explain  The Times of India

Events

3 w. ago Trump's 100% tariffs on branded drugs: Indian generics spared but pose risks for pharma sector – Explaine

Trump's 100% tariffs on branded drugs: Indian generics spared but pose risks for pharma sector – Explaine  The Times of India

Events

3 w. ago Indian pharma stocks fall after Trump's new drug tariffs; mostly 'sentimental', say analysts

Indian pharma stocks fall after Trump's new drug tariffs; mostly 'sentimental', say analysts  Reuters

Politics

3 w. ago Trump Tariffs May Not Hurt Indian Companies, Says Morgan Stanley: THIS Pharma Stock An Exception

Morgan Stanley believes the impact could be limited, as far as the Indian market is concerned. However, companies like Sun Pharma could be at risk due to their speciality drug presence in the US.

Politics

3 w. ago The impact of Trump tariffs on Indian Pharma is limited at best. Here's why | Business News

The impact of Trump tariffs on Indian Pharma is limited at best. Here's why | Business News  Hindustan Times

Politics

3 w. ago The impact of Trump tariff on Indian Pharma is limited at best. Here's why | Business News

The impact of Trump tariff on Indian Pharma is limited at best. Here's why | Business News  Hindustan Times

Politics

3 w. ago The impact of Trump tariff on Indian Pharma is limited at best | Business News

The impact of Trump tariff on Indian Pharma is limited at best | Business News  Hindustan Times

Politics

3 w. ago Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in

Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in  Times of India

Politics